Joseph Bresee
Overview
Explore the profile of Joseph Bresee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
4034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nunes M, Chauvel C, Raboni S, Lopez-Labrador F, Andrew M, Badar N, et al.
Influenza Other Respir Viruses
. 2025 Mar;
19(3):e70091.
PMID: 40082217
Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance...
2.
Otieno N, Kalani R, Ayugi J, Nyawanda B, Ndegwa L, Osoro E, et al.
Vaccine
. 2025 Mar;
54:126963.
PMID: 40058283
Introduction: Data about healthcare workers' (HCW) willingness to accept and recommend seasonal influenza vaccination in countries without influenza vaccination programs are limited. Methods: We conducted a cross-sectional survey in 7...
3.
Lane M, Luke C, Bresee J, Dugan V, Post D, Schafer J, et al.
Influenza Other Respir Viruses
. 2024 Oct;
18(10):e13358.
PMID: 39440405
On November 13-14, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) in partnership with the Task Force for Global Health, Flu Lab, the Canadian Institutes of Health Research,...
4.
Gobin S, Sahakyan G, Kusi Appiah M, Manukyan A, Palayan K, Ebama M, et al.
Vaccine
. 2024 Jun;
42 Suppl 4:126007.
PMID: 38839517
Background: Despite the substantial global impact of influenza, there are limited economic data to guide influenza vaccination programs investments in middle-income countries. We measured the costs of influenza and the...
5.
Dawa J, Jalango R, Mirieri H, Kalani R, Marwanga D, Lafond K, et al.
Vaccine
. 2023 Dec;
42 Suppl 4:125461.
PMID: 38105140
Introduction: In 2016, the Kenya National Immunization Technical Advisory Group requested additional programmatic and cost effectiveness data to inform the choice of strategy for a national influenza vaccination program among...
6.
Bresee J, Koh M, Chadwick C, Jit M, Soble A, Lambach P
Vaccine
. 2023 Oct;
41(48):7044-7046.
PMID: 37872012
No abstract available.
7.
Cohen L, Hansen C, Andrew M, McNeil S, Vanhems P, Kyncl J, et al.
J Infect Dis
. 2023 Aug;
229(4):999-1009.
PMID: 37527470
Background: The Global Influenza Hospital Surveillance Network (GIHSN) has since 2012 provided patient-level data on severe influenza-like-illnesses from >100 participating clinical sites worldwide based on a core protocol and consistent...
8.
Andrew M, Pott H, Staadegaard L, Paget J, Chaves S, Ortiz J, et al.
Open Forum Infect Dis
. 2023 Jun;
10(6):ofad244.
PMID: 37383245
Background: The Global Influenza Hospital Surveillance Network (GIHSN) was established in 2012 to conduct coordinated worldwide influenza surveillance. In this study, we describe underlying comorbidities, symptoms, and outcomes in patients...
9.
Attia R, Abubakar A, Bresee J, Mere O, Khan W
Influenza Other Respir Viruses
. 2023 Mar;
17(3):e13126.
PMID: 36970569
Background: Although there has been an effective seasonal influenza vaccine available for more than 60 years, influenza continues to circulate and cause illness. The Eastern Mediterranean Region (EMR) is very...
10.
Waterlow N, Radhakrishnan S, Dawa J, van Leeuwen E, Procter S, Lambach P, et al.
BMC Med
. 2023 Mar;
21(1):106.
PMID: 36949456
Background: Influenza is a major year-round cause of respiratory illness in Kenya, particularly in children under 5. Current influenza vaccines result in short-term, strain-specific immunity and were found in a...